This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chan, K. H.
Right arrow Articles by Peiris, J. S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chan, K. H.
Right arrow Articles by Peiris, J. S. M.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, November 1998, p. 3359-3361, Vol. 36, No. 11
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Development and Evaluation of an Epstein-Barr Virus (EBV) Immunoglobulin M Enzyme-Linked Immunosorbent Assay Based on the 18-Kilodalton Matrix Protein for Diagnosis of Primary EBV Infection

K. H. Chan,1 R. X. Luo,2 H. L. Chen,3 M. H. Ng,2 W. H. Seto,1 and J. S. M. Peiris2,*

Department of Microbiology, Queen Mary Hospital,1 and The University of Hong Kong,2 Hong Kong, and Department of Pharmacology and Molecular Science, School of Medicine, John Hopkins University, Baltimore, Maryland3

Received 14 May 1998/Returned for modification 7 July 1998/Accepted 19 August 1998

A new immunoglobulin M (IgM) enzyme-linked immunosorbent assay (ELISA) based on the recombinant Epstein-Barr virus (EBV) matrix protein was developed. Compared to indirect immunofluorescence for the detection of IgM antibody to the EBV capsid antigen on clinical specimens, the sensitivity and specificity of the new IgM ELISA were 96 and 96%, respectively.

* Corresponding author. Mailing address: Department of Microbiology, University Pathology Building, Queen Mary Hospital Compound, Pokfulam, Hong Kong. Phone: (852) 2855 4888. Fax: (852) 2855 1241. E-mail: microgen{at}hkucc.hku.hk.

Journal of Clinical Microbiology, November 1998, p. 3359-3361, Vol. 36, No. 11
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Casey, J.L., Coley, A.M., Parisi, K., Foley, M. (2009). Peptide mimics selected from immune sera using phage display technology can replace native antigens in the diagnosis of Epstein-Barr virus infection. Protein Eng Des Sel 22: 85-91 [Abstract] [Full Text]  
  • Fachiroh, J., Paramita, D. K., Hariwiyanto, B., Harijadi, A., Dahlia, H. L., Indrasari, S. R., Kusumo, H., Zeng, Y. S., Schouten, T., Mubarika, S., Middeldorp, J. M. (2006). Single-Assay Combination of Epstein-Barr Virus (EBV) EBNA1- and Viral Capsid Antigen-p18-Derived Synthetic Peptides for Measuring Anti-EBV Immunoglobulin G (IgG) and IgA Antibody Levels in Sera from Nasopharyngeal Carcinoma Patients: Options for Field Screening. J. Clin. Microbiol. 44: 1459-1467 [Abstract] [Full Text]  
  • Casey, J. L., Coley, A. M., Street, G., Parisi, K., Devine, P. L., Foley, M. (2006). Peptide mimotopes selected from a random Peptide library for diagnosis of epstein-barr virus infection.. J. Clin. Microbiol. 44: 764-771 [Abstract] [Full Text]  
  • Chan, K. H., Ng, M. H., Seto, W. H., Peiris, J. S. M. (2001). Epstein-Barr Virus (EBV) DNA in Sera of Patients with Primary EBV Infection. J. Clin. Microbiol. 39: 4152-4154 [Abstract] [Full Text]  
  • Hinderer, W., Lang, D., Rothe, M., Vornhagen, R., Sonneborn, H. H., Wolf, H. (1999). Serodiagnosis of Epstein-Barr Virus Infection by Using Recombinant Viral Capsid Antigen Fragments and Autologous Gene Fusion. J. Clin. Microbiol. 37: 3239-3244 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»